Oxford Nanopore Technologies's EBIT per Share for the
six
months ended in Dec. 2025 was $-0.39.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.77.
During the past 3 years, the average EBIT per Share Growth Rate was -10.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -7.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Oxford Nanopore Technologies's EBIT per Share or its related term are showing as below:
OXFYY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -42.4 Med: -10.5 Max: 8.9
Current: -10.5
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Oxford Nanopore Technologies was 8.90% per year. The lowest was -42.40% per year. And the median was -10.50% per year.
OXFYY's 3-Year EBIT Growth Rate is ranked worse than 80.24% of 1179
companies
in the Biotechnology industry
Industry Median: 15.6
vs OXFYY: -10.50
Oxford Nanopore Technologies (OTCPK:OXFYY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Oxford Nanopore Technologies EBIT per Share Related Terms
Oxford Nanopore Technologies EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford Nanopore Technologies (OXFYY) has a EBIT per Share of $-0.77 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Oxford Nanopore Technologies and its competitors. According to the industry distribution chart, Oxford Nanopore Technologies ranks #946 out of 1179 companies in the Biotechnology industry, placing it in the top 80.2%.
Is Oxford Nanopore Technologies' EBIT per Share too high?
Oxford Nanopore Technologies' current EBIT per Share is $-0.77. Based on the distribution chart, Oxford Nanopore Technologies ranks #946 out of 1179 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oxford Nanopore Technologies has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #946 out of 1179 companies for EBIT per Share. This places Oxford Nanopore Technologies in the lower half of its industry. The industry median EBIT per Share is 15.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.60, based on 1,179 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Oxford Nanopore Technologies and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current EBIT per Share is $-0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (OXFYY) is currently considered Significantly Undervalued. The stock's GF Value™ is $10.41, compared to a current price of $6.50 — trading 37.6% below its estimated fair value. The current EBIT per Share is $-0.77. Oxford Nanopore Technologies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Oxford Nanopore Technologies (OXFYY), the current EBIT per Share is $-0.77 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?
Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued.
The current stock price of $6.50 is trading 37.6% below its estimated GF Value™ of $10.41.
GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.
Key valuation signals for OXFYY:
EBIT per Share: $-0.77
GF Value™: $10.41 vs. price of $6.50 (37.6% below fair value)
No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score
Get the complete analysis for OXFYY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OXFYY has been successfully added to your 
